Robert Mcleod Email & Phone Number

Barcelona, Ct, Es

London, Gb

I am responsible for managing preclinical programs, developing the clinical strategy and leading the clinical development of Myricx's proprietary ADCs comprising monoclonal antibodies conjugated to selective cytotoxic payloads based on N-myristoyltransferase (NMT) inhibitors.

Basking Ridge, Nj, Us

As Oncology Global Clinical Lead in Early Phase R&D at Daiichi Sankyo, I provided strategic leadership for clinical development of multiple antibody-drug conjugates for solid tumors. Key responsibilities included spearheading first-in-human trials, collaborating with scientists on biomarkers, serving on the Safety Committee, preparing clinical plans, providing clinical input on regulatory submissions, engaging with key opinion leaders, and moderating advisory boards. I led multifunctional teams to advance novel ADCs from preclinical to early phase global clinical trials.

London, Gb

As a Clinical Research Physician at Cancer Research UK's Centre for Drug Development, I led early phase oncology clinical trials and translational medicine initiatives. Key responsibilities included overseeing preclinical and early clinical projects across a broad portfolio of cancer therapies, designing and monitoring early phase studies with a focus on biomarkers, authoring integrated drug development plans, and engaging with academic leaders to optimize clinical trial strategies. I provided medical expertise to advance Cancer Research UK's mission of bringing innovative new treatments to cancer patients.

Gaithersburg, Maryland, Us

As Senior Director of Clinical Strategy at Emergent BioSolutions key responsibilities included strategic and operational leadership for clinical trials evaluating viral and bacterial vectored vaccines for tuberculosis, influenza, RSV, typhoid and hepatitis. I worked with global teams to advance vaccines from preclinical through late phase trials, interacted with regulatory agencies, and authored clinical sections of regulatory submissions.

Gaithersburg, Maryland, Us

Vaccine clinical development

Basel, Baselstadt, Ch

Transitioned to Novartis following acquisition of Chiron

Initially Global Paediatric vaccine franchise, followed by broader portfolio including Influenza, Adult, Travel and Meningitis vaccines for International markets.

Preclinical development with focus on oncology, CVS and metabolic disease

St Vincent's Hospital, MelbourneBox Hill Hospital, MelbourneCharing Cross Hospital, London

Medicine

Mba, Business Studies

Postgraduate Course In Pharmaceutical Medicine